Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher McCabe

Showing results (51-60 of 150) with videos related to

Pageof 15
Sort By:
Pharmacoeconomics|June 17, 2021
A Net Benefit Approach for the Optimal Allocation of a COVID-19 VaccineErin Kirwin, Ellen Rafferty, Kate Harback, et al.
Pharmacoeconomics|December 17, 2019
One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net BenefitChristopher McCabe, Mike Paulden, Isaac Awotwe, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 12, 2007
GADD34 gene restores virulence in viral vector used in experimental stroke studyChristopher McCabe, Fiona White, S Moira Brown, et al.
PLOS Global Public Health|March 24, 2023
Vaccine rollout strategies: The case for vaccinating essential workers earlyNicola Mulberry, Paul Tupper, Erin Kirwin, et al.
Pharmacoeconomics|November 22, 2014
Objectivity and equity: clarity required. A response to Hill and OlsonMike Paulden, James F O'Mahony, Anthony J Culyer, et al.
Neuropharmacology|September 20, 2017
Animal models of ischaemic stroke and characterisation of the ischaemic penumbraChristopher McCabe, Mariana M Arroja, Emma Reid, et al.
Pharmacoeconomics|July 9, 2013
Constructing indirect utility models: some observations on the principles and practice of mapping to obtain health state utilitiesChristopher McCabe, Richard Edlin, David Meads, et al.
Journal of the National Cancer Institute|December 6, 2011
Economic evaluation of genomic test-directed chemotherapy for early-stage lymph node-positive breast cancerPeter S Hall, Christopher McCabe, Robert C Stein, et al.
Pharmacoeconomics|August 23, 2014
Some inconsistencies in NICE's consideration of social valuesMike Paulden, James F O'Mahony, Anthony J Culyer, et al.
Pharmacoeconomics|November 23, 2020
Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit FrontierChristopher McCabe, Giovanni Tramonti, Andrew Sutton, et al.
Pageof 15

Showing results (51-60 of 150) with videos related to

Sort By:
Pageof 15
Pharmacoeconomics|June 17, 2021
A Net Benefit Approach for the Optimal Allocation of a COVID-19 VaccineErin Kirwin, Ellen Rafferty, Kate Harback, et al.
Pharmacoeconomics|December 17, 2019
One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net BenefitChristopher McCabe, Mike Paulden, Isaac Awotwe, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 12, 2007
GADD34 gene restores virulence in viral vector used in experimental stroke studyChristopher McCabe, Fiona White, S Moira Brown, et al.
PLOS Global Public Health|March 24, 2023
Vaccine rollout strategies: The case for vaccinating essential workers earlyNicola Mulberry, Paul Tupper, Erin Kirwin, et al.
Pharmacoeconomics|November 22, 2014
Objectivity and equity: clarity required. A response to Hill and OlsonMike Paulden, James F O'Mahony, Anthony J Culyer, et al.
Neuropharmacology|September 20, 2017
Animal models of ischaemic stroke and characterisation of the ischaemic penumbraChristopher McCabe, Mariana M Arroja, Emma Reid, et al.
Pharmacoeconomics|July 9, 2013
Constructing indirect utility models: some observations on the principles and practice of mapping to obtain health state utilitiesChristopher McCabe, Richard Edlin, David Meads, et al.
Journal of the National Cancer Institute|December 6, 2011
Economic evaluation of genomic test-directed chemotherapy for early-stage lymph node-positive breast cancerPeter S Hall, Christopher McCabe, Robert C Stein, et al.
Pharmacoeconomics|August 23, 2014
Some inconsistencies in NICE's consideration of social valuesMike Paulden, James F O'Mahony, Anthony J Culyer, et al.
Pharmacoeconomics|November 23, 2020
Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit FrontierChristopher McCabe, Giovanni Tramonti, Andrew Sutton, et al.
Pageof 15